文献速递炎症性肠病

炎症性肠病中的黏附侵袭性大肠杆菌

Adherent-invasive Escherichia coli in inflammatory bowel disease.
PubMed 文献 · Gut · 2017-11-15

本文综述炎症性肠病(IBD)中黏附侵袭性大肠杆菌(AIEC)的致病作用,总结其黏附与逃逸自噬的机制、在克罗恩病和溃疡性结肠炎中的流行率及与病变部位、活动度和术后复发的关联,并探讨靶向AIEC定植的潜在治疗策略。

要点

  • AIEC通过FimH与细胞黏附分子6黏附肠上皮细胞,并在巨噬细胞内逃逸自噬。
  • 综述汇总AIEC在克罗恩病和溃疡性结肠炎患者中的流行率及其与病变部位、活动度和术后复发的关联。
  • 噬菌体疗法、细菌素和抗黏附分子等靶向AIEC定植的策略可能为IBD防治开辟新途径。

核心结论

  • AIEC与IBD发病相关,靶向AIEC肠道黏膜定植的策略可能为未来IBD的预防和治疗开辟新途径。

研究设计与样本

  • 综述,回顾AIEC发现二十年来的研究进展,汇总AIEC在克罗恩病和溃疡性结肠炎患者中的流行率数据及其与病变部位、活动度和术后复发的关联。

主要发现

  • AIEC通过FimH与细胞黏附分子6黏附肠上皮细胞,并能在巨噬细胞内逃逸自噬。
  • 综述汇总了AIEC在克罗恩病和溃疡性结肠炎患者中的流行率及与病变部位、活动度和术后复发的关联。
  • 靶向AIEC肠道黏膜定植的潜在策略包括噬菌体疗法、细菌素和抗黏附分子。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intestinal microbiome dysbiosis has been consistently described in patients with IBD. In the last decades, Escherichia coli, and the adherent-invasive E coli (AIEC) pathotype in particular, has been implicated in the pathogenesis of IBD. Since the discovery of AIEC, two decades ago, progress has been made in unravelling these bacteria characteristics and its interaction with the gut immune system. The mechanisms of adhesion of AIEC to intestinal epithelial cells (via FimH and cell adhesion molecule 6) and its ability to escape autophagy when inside macrophages are reviewed here. We also explore the existing data on the prevalence of AIEC in patients with Crohn's disease and UC, and the association between the presence of AIEC and disease location, activity and postoperative recurrence. Finally, we highlight potential therapeutic strategies targeting AIEC colonisation of gut mucosa, including the use of phage therapy, bacteriocins and antiadhesive molecules. These strategies may open new avenues for the prevention and treatment of IBD in the future.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Palmela C, Chevarin C, Xu Z, et al. Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut. 2017. PMID: 29141957. doi:10.1136/gutjnl-2017-314903

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。